Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline patient demographics: Pooled subgroup analysis from two randomized phase 3 studies

被引：0
|
作者：
Papp, Kim [1 ]
Szepietowski, Jacek C. [2 ]
Kircik, Leon [3 ]
Toth, Darryl [4 ]
Eichenfield, Lawrence F. [5 ]
Forman, Seth B. [6 ]
Armstrong, April W. [7 ]
Kuligowski, Michael E. [8 ]
Venturanza, May E. [8 ]
Sun, Kang [8 ]
Simpson, Eric L. [9 ]
机构：
[1] Papp Clin Res & Prob Med Res, Waterloo, ON, Canada
[2] Wroclaw Med Univ, Wroclaw, Poland
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[4] Med Res & Prob Med Res, New York, NY USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
[6] ForCare Clin Res, Tampa, FL USA
[7] Univ Southern Calif, Los Angeles, CA 90089 USA
[8] Incyte Corp, Wilmington, DE USA
[9] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27496
引用
收藏
页码：AB149 / AB149
页数：1
相关论文
共 50 条
  • [21] Effects of ruxolitinib cream on pruritus and sleep in atopic dermatitis: 52-week pooled results from two phase III studies
    Simpson, E. L.
    Boguniewicz, M.
    Thaci, D.
    Misery, L.
    Armstrong, A. W.
    Silverberg, J. I.
    Venturanza, M. E.
    Kallender, H.
    Gao, J.
    Szepietowski, J. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E166 - E167
  • [22] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: pooled results from two phase III studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Eichenfield, L. F.
    Forman, S. B.
    Kuligowski, M. E.
    Venturanza, M. E.
    Ren, H.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E167 - E167
  • [23] Effects of ruxolitinib cream on patient-reported quality of life in atopic dermatitis: 52-week pooled results from two phase III studies
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Armstrong, April W.
    Fuxench, Zelma C. Chiesa
    Venturanza, May E.
    Kallender, Howard
    Gao, Jessy
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E122 - E123
  • [24] Effects of ruxolitinib cream in patients with atopic dermatitis with baseline body surface area ≥10% and Eczema Area and Severity Index score ≥16: Pooled results from two phase 3 studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Eichenfield, Lawrence F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB157 - AB157
  • [25] SUBGROUP ANALYSIS OF QUALITY-OF-LIFE OUTCOMES IN PATIENTS ACHIEVING F-VASI75: POOLED RESULTS FROM TWO RANDOMIZED PHASE 3 STUDIES OF RUXOLITINIB CREAM FOR THE TREATMENT OF VITILIGO
    Pandya, A. G.
    van Geel, N.
    Butler, K.
    Bibeau, K.
    Gao, J.
    Ezzedine, K.
    VALUE IN HEALTH, 2022, 25 (07) : S328 - S328
  • [26] Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Kuligowski, Michael E.
    Kallender, Howard
    Sun, Kang
    Ren, Haobo
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : 1008 - 1016
  • [27] Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis: Results From Two Phase 3 Studies
    Papp, K.
    Szepietowski, J.
    Kircik, L.
    Toth, D.
    Eichenfield, L.
    Forman, S.
    Kuligowski, M.
    Venturanza, M.
    Sun, K.
    Simpson, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S184 - S184
  • [28] Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
    Xiaohua Gong
    Xuejun Chen
    Michael E. Kuligowski
    Xing Liu
    Xiang Liu
    Evan Cimino
    Ryan McGee
    Swamy Yeleswaram
    American Journal of Clinical Dermatology, 2021, 22 : 555 - 566
  • [29] Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
    Gong, Xiaohua
    Chen, Xuejun
    Kuligowski, Michael E.
    Liu, Xing
    Liu, Xiang
    Cimino, Evan
    McGee, Ryan
    Yeleswaram, Swamy
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 555 - 566
  • [30] Efficacy and safety of ruxolitinib cream for the treatment of vitiligo: Week 24 pooled analysis of the TRuE-V phase 3 studies
    Rosmarin, David
    Ezzedine, Khaled
    Desai, Seemal R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB51 - AB51
12345